The true culprit within the SPINK1 p.N34S-containing haplotype is still at large

Gut

Volumn 58, Issue 4, 2009, Pages 478-480

  Chen, Jian Min ^a,b,c,d   Férec, Claude ^a,b,c,d,e  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^d Institut Federatif de Recherche IFR 148   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; SERINE PROTEASE INHIBITOR KAZAL TYPE 1; TRYPSIN; UNCLASSIFIED DRUG;

ACINAR CELL; CHRONIC PANCREATITIS; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MISSENSE MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARRIER PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MUTATION, MISSENSE; PANCREATITIS, CHRONIC;

EID: 63849216708     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.170191     Document Type: Note

References (25)

1. Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980;49:593-626.
2. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nst Genet 1996;14:141-5.
3. Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-8.
4. Chen JM, Mercier B, Audrézet MP, et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000;37:67-9.
5. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-6.
6. Le Marechal C, Chen JM, Le Gall C, et al. Two novel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial and/or hereditary pancreatitis. Hum Mutat 2004;23:205.
7. Gaia E, Salacone P, Gallo M, et al. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002;47:2416-21.
8. Kume K, Masamune A, Kikuta K, et al.[-215G>A; IVS3+2T>C] mutation in the SPINK1 gene causes exon 3 skipping and loss of the trypsin binding site. Gut 2006;55:1214.
9. Masson E, Le Marechal C, Chen JM, et al. Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 2006;14:1204-8.
10. Masson E, Le Maréchal C, Levy P, et al. Co- inheritance of a novel deletion of the entire SPINK1 gene with a CFTR missense mutation (L997F) in a family with chronic pancreatitis. Moi Genet Metab 2007;92:168-75.
11. Kiraly O, Boulling A, Witt H, et al. Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat 2007;28:469-76.
12. Boulling A, Le Maréchal C, Trouvé P, et al. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 2007;15:936-42.
13. Pfiitzer RH, Barmada MM, Brunskill AP, et al. SPINK1 /PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
14. Kiraly O, Wartmann T, Sahin-Toth M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 2007;56:1433-8.
15. Schneider A, Suman A, Rossi L, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002;123:1026-30.
16. Ockenga J, Dörk T, Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet 2001;38:243-4.
17. Kuwata K, Hirota M, Sugita H, et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol 2001;36:612-8.
18. Aoun E, Chang CC, Greer JB, et al. Pathways to injury in chronic pancreatitis: decoding the role of the high- risk SPINK1 N34S haplotype using meta-analysis. PLoS ONE 2008;3:e2003.
19. Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007;132:1557-73.
20. Kuwata K, Hirota M, Nishimori I, et al. Mutational ana ysis of the pancreatic secretory trypsin inhibitor gene in familial and juvenile pancreatitis in Japan. J Gastroentero 2003;38:365-70.
21. Kuwata K, Hirota M, Shimizu H, et al. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroentero 2002;37:928-34.
22. Chen JM, Mercier B, Audrézet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001;120:1061-1.
23. Masamune A, Kume K, Takagi Y, et al. N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas 2007;34:423-8.
24. Kereszturi E, Kiraly 0, Sahin-Toth M. Minigene analysis of intronic variants in common SPINK1 haplotypes associated with chronic pancreatitis. Gut 2009;58:545-9.
25. Shimosegawa T, Kume K, Masamune A. SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan. J Gastroentero Hepato 2008;23:S82-6.